What Rabin Martin does

Rabin Martin is a global health strategy consultancy founded in 2002 (formerly Rabin Strategic Partners) and headquartered in New York, with a second office in London. The firm designs, develops, and delivers bespoke health programs for large multinational pharmaceutical companies (GSK, AbbVie, Roche, Novo Nordisk, Takeda, Johnson & Johnson, Novartis, UCB, AstraZeneca, Merck) and major global health foundations (Bill & Melinda Gates, Robert Wood Johnson, Rockefeller, Merck Foundation, New York Academy of Medicine). Across more than two decades it has managed over $2 billion of health programming in 80+ markets spanning high-, middle-, and low-income countries, with marquee programs including Merck for Mothers ($650 million cumulative initiative since 2011), Healthy Heart Africa (with AstraZeneca, screening 47 million+ people across nine sub-Saharan Africa countries since 2014), and multi-party commissions on rare disease and chronic disease in pregnancy.

The firm's service offering is organized around five practice areas (Signature Initiatives & Program Development; Coalition Building & Partnerships; Policy Analysis & Stakeholder Engagement; Health Equity Strategy & Programming; Thought Leadership & Corporate Positioning) layered on a four-phase execution spine (Strategy, Solution, Implementation, Measure and Evaluate). Its only documented proprietary asset is the ONPOINTTM Framework for designing partnership and program strategies. There is no technology product, software, API, or AI/ML capability — the firm's output is human-expert advisory and program management, often with the firm acting as secretariat for multi-party coalitions (PSRT, Advancing Health Online, BRIDGE).

Revenue is generated through custom-priced consulting engagements with no public rate card. The go-to-market motion is sales-led B2B, leveraging senior-level relationships, conference presence (World Health Assembly, IMNHC), thought leadership content, and white papers (including sponsored Harvard Business Review Analytic Services reports). The firm is privately held with no disclosed external investors or parent company, was rebranded from Rabin Strategic Partners, and is led by Managing Partner & CEO Rajni Samavedam (joined November 2022).

Name

Rabin Martin

Legal name

Rabin Martin

Website

https://rabinmartin.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Global health strategy consultancy founded in 2002 that designs and implements signature health programs for major pharmaceutical companies and global health foundations, with offices in New York and London and operations spanning 80+ markets.

Ownership category

akta.pro rank

Product category

Health Strategy Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618), Professional, Scientific, and Technical Services (541)

SIC

Services-Management Consulting Services (8742), Services-Management Services (8741)

akta.pro primary industry

Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO)

Keywords

• Global health consulting
• Health strategy advisory
• Pharmaceutical consulting
• Health equity advisory
• Health program design

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Strategic Health Consulting Services: Rabin Martin generates revenue through consulting engagements with pharmaceutical companies, foundations, NGOs, and government agencies. Services include strategy development, program design, implementation support, coalition building, policy analysis, and measurement/evaluation. Engagements are customized and managed from start to finish, serving clients globally across 80+ markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Rabin Martin is a global health consultancy that designs, develops, and delivers health strategy solutions for pharmaceutical companies, foundations, NGOs, and government agencies. The firm manages engagements end-to-end across strategy development, program design and implementation, coalition building, policy analysis, and measurement and evaluation, with deep focus on expanding access to medicines and improving health equity across 80+ markets.

Product overview

Rabin Martin is a global health consultancy firm that offers a comprehensive suite of advisory services organized around five core practice areas: Signature Initiatives & Program Development, Coalition Building & Partnerships, Policy Analysis & Stakeholder Engagement, Health Equity Strategy & Programming, and Thought Leadership & Corporate Positioning. The firm also provides foundational consulting services including Strategy, Solution Development, Implementation, and Measure and Evaluate. These services work together to help clients design, develop, and deliver effective solutions to unlock new markets and opportunities in global health. The firm operates across multiple therapeutic areas including cancer, maternal health, HIV/AIDS, vaccines, rare diseases, and more, serving pharmaceutical companies, foundations, and global health organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategy Consulting

Quantifiable outcome

• Managed $2 billion+ in health programming across 80+ markets
• +3 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and flagship.

• Merck & Co., Inc. and Meta (Advancing Health Online)coreStrategic or Co-development Partner · 1 January 2021Rabin Martin serves as the Secretariat for Advancing Health Online (AHO), an initiative launched by Merck and Meta to better understand how social media and behavioral science can improve health outcomes. The firm guides multi-year strategy, investment decisions, and partnership development.
• Takeda, Microsoft, and EURORDIS (Global Commission to End the Diagnostic Odyssey)flagshipStrategic or Co-development Partner · 1 January 2019Rabin Martin designed and supports Takeda's Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease. The Commission, co-chaired by Takeda, Microsoft and EURORDIS, developed actionable recommendations to reduce time to diagnosis for rare diseases.
• Johnson & Johnson and GE Foundation (Private Sector Roundtable on Global Health Security)flagshipStrategic or Co-development Partner · 1 January 2015In collaboration with founding co-chairs Johnson & Johnson and GE Foundation, Rabin Martin established the Private Sector Roundtable on Global Health Security (PSRT) in 2015. The PSRT provides the industry voice on global health security matters and advocates for greater private sector engagement in health emergencies.
• AstraZeneca (Healthy Heart Africa)flagshipStrategic or Co-development Partner · 1 January 2014Rabin Martin collaborated with AstraZeneca to create and design Healthy Heart Africa, a signature initiative to expand access to screening and treatment for cardiovascular disease. The program launched in Kenya in 2014 and has since expanded to 9 countries across sub-Saharan Africa.
• Merck & Co., Inc. (Merck for Mothers)flagshipStrategic or Co-development Partner · 1 January 2011Rabin Martin has served as Merck for Mothers' lead consultant for more than a dozen years. The firm guided strategy, program design and implementation for Merck's $650 million initiative to end preventable maternal deaths worldwide. Initially a $500 million, 10-year program launched in 2011, extended with additional $150 million in 2021.
• UCB (BRIDGE Commission)coreStrategic or Co-development PartnerRabin Martin worked with UCB to establish the BRIDGE (Better Research, Information and Data Generation for Empowerment) commission - a global multidisciplinary commission examining limited data on pregnancy and chronic disease, developing action-oriented recommendations for women to make informed treatment decisions.
• Bill & Melinda Gates FoundationcoreStrategic or Co-development PartnerRabin Martin supports the Bill & Melinda Gates Foundation's strategy to ensure effective introduction of new maternal vaccines. The firm develops convenings, sessions, and comprehensive reports to align stakeholders on policy, delivery, and country-level preparedness for maternal immunization.
• Merck Foundation (Alliance for Equity in Cancer Care)coreStrategic or Co-development PartnerRabin Martin supported the development of the Alliance for Equity in Cancer Care - a $20 million, five-year national initiative funded by the Merck Foundation to increase access to high-quality, equitable cancer care for underserved communities in the United States.
• Gavi, the Vaccine Alliance (VaxSocial)coreStrategic or Co-development PartnerThrough the Advancing Health Online initiative, Rabin Martin facilitates partnership between Merck, Meta, and Gavi on VaxSocial - supporting innovative social media and behavioral science solutions to build vaccine confidence in India, Indonesia, and Nigeria.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• FHI 360: FHI 360 is a global health and social development organization that designs and implements programs across therapeutic and public health areas, serving both foundation and large pharma clients with strategy-to-implementation services.
• Palladium: Palladium operates global health programs with pharma, foundations, and bilateral donors, with services spanning program design, coalition building, and implementation — directly mirroring Rabin Martin's end-to-end global health engagement model.
• Dalberg Global Development Advisors: Dalberg is a global strategy consultancy dedicated to international development, with deep global health and pharma/Founder Foundation practices. Most directly comparable boutique-style firm serving the same multinational pharma and major foundation client base.
• RTI International: RTI International is a nonprofit research institute providing research, consulting, and program implementation services with a substantial global health practice serving foundations and pharma.
• Clinton Health Access Initiative (CHAI): CHAI is a global health access organization that partners with governments and pharma to expand access to medicines in LMICs. Strong overlap with Rabin Martin on pharma access strategy, market-shaping, and coalition-led program delivery.
• ThinkWell: ThinkWell is a health systems and global health consultancy serving governments, donors, and pharma. Comparable in size, niche, and the mix of strategy and program design work for global health clients.
• Results for Development (R4D): R4D is a global health and education consultancy that partners with foundations and pharma to design, implement, and evaluate programs — a near-direct functional peer in global health strategy and measurement work.

Broad incumbents

• Abt Global: Abt Global is a large consulting and research firm with a substantial global health practice serving foundations and government clients. Broader portfolio but with overlapping global health strategy, evaluation, and access work.
• McKinsey (Global Public Health Practice): McKinsey's Global Public Health practice serves large pharma and foundations on strategy, access, and population health issues. Larger incumbent offering comparable services but as part of a wider portfolio, not a specialized global health boutique.
• Boston Consulting Group (Healthcare & Global Health): BCG's Healthcare and Global Health practices advise large pharma and foundations on access strategy, equity, and impact. Broader strategic consulting incumbent with overlapping global health engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rabin-martin
• Xx.com/rabinmartin

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rabin Martin